1.Molecular characterization of two Malaysian patients with Wiskott-Aldrich syndrome
Mohd Farid Baharin ; Sabeera Begum Kader Ibrahim ; Yap Song Hong ; Aina Mariana Abdul Manaf ; Adiratna Mat Ripen ; Jasbir Singh Dhaliwal
The Malaysian Journal of Pathology 2015;37(2):153-158
The Wiskott-Aldrich Syndrome (WAS) is an X-linked immunodeficiency condition characterized
by microthrombocytopenia, eczema and recurrent infections. It is caused by mutations in the
Wiskott-Aldrich Syndrome protein (WASP) gene. We investigated two Malay boys who presented
with congenital thrombocytopenia, eczema and recurrent infections. Here we report two cases of
WASP mutation in Malaysia from two unrelated families. One had a novel missense mutation in
exon 1 while the other had a nonsense mutation in exon 2. Both patients succumbed to diseaserelated
complications. A differential diagnosis of WAS should be considered in any male child
who present with early onset thrombocytopenia, especially when this is associated with eczema
and recurrent infections.
2.Clinical spectrum of children receiving palliative care in Malaysian Hospitals
Lee Ai Chong ; Farah Khalid ; Teik Beng Khoo ; Siao Hean The ; Geok Lan Kuan ; Aina Mariana Abdul Manaf ; Emieliyuza Alias ; Chae Hee Chieng ; Hadibiah Razali ; Gek Bee Ong ; Zainah Shaikh Hedra ; Intan Nor Chahaya Abdul Shukor ; Jia Jia Wong
The Medical Journal of Malaysia 2017;72(1):32-36
Introduction: Awareness for paediatric palliative care has
resulted in the impetus for paediatrician-led palliative care
services across Malaysia. However, there is paucity of local
data on patients receiving hospital-based paediatric
palliative care. We aim to review the clinical spectrum of
patients referred to these services.
Methods: An observational study of children aged between
0-18 years receiving palliative care at 13 hospitals between
1st January and 31st December 2014 was carried out.
Results: There were 315 patients analysed, 90 (28.6%) and
46 (14.6%) were neonates and adolescents respectively. The
main ICD-10 diagnostic categories for all patients were
identified to be ‘Congenital malformations, deformations
and chromosomal abnormalities’ 117 (37.1%), ‘Diseases of
nervous system’ 76 (24.1%) and ‘Neoplasms’ 60 (19.0%). At
referral 156 (50%) patients had holistic needs assessments.
Patients with ‘Diseases of nervous system’ were assessed
to have significantly more physical needs than the other two
diagnostic categories. Majority of patients who knew of their
diagnosis and prognosis were those with malignancy. Over
a fifth of referrals were at their terminal admission. Of 144
who died, 111 (77.1%) had advanced care plans. There was
bereavement follow-up in 98 (68.1%) patients.
Conclusion: Patients referred for palliative care have varied
diagnoses and needs. To ensure all paediatricians are
competent to deliver quality care to all children, further
education and training initiatives is imperative.
Palliative Care
3.Varicella and isolated acute peripheral facial nerve palsy: A systematic review on natural history, prognosis and treatment
Lip Yuen Teng ; Wai Quen Lee ; Aina Mariana Binti Abdul Manaf
Neurology Asia 2020;25(4):473-484
Background & Objective: Varicella is a common infection during childhood and generally self-limiting.
However, it can rarely cause neurological complications. Isolated acute peripheral facial palsy (APFP)
is extremely rare during primary varicella infection with estimated incidence of <0.01%. There have
also been conflicting opinions on its natural history, prognosis and management worldwide. We
aimed to establish the natural history, prognosis and treatment for varicella-related isolated APFP
in immunocompetent individuals, without co-morbids. Methods: Systematic review was performed
with systematic literature search in Google Scholar and PubMed. Data was analysed with statistical
analysis software.
Results: Thirty cases were included. The complete remission rate of APFP was 66.67% for nontreatment group and 72.22% for treatment group (p=0.643). Early and late treatment group had a similar complete remission rate of 88.89% and 80% respectively (p=1.000). However, early treatment group (within 3 days of onset) had achieved complete remission 3 weeks earlier than the late treatment group (p=0.091). Antiviral group tends to have better outcome than steroid monotherapy group, although statistically insignificant (p=0.055).
Conclusions: This condition generally has good prognosis even without treatment. However, early
treatment and antiviral therapy may at least accelerate remission and reduce morbidities although these cannot alter the final outcome. Clinicians may consider antiviral therapy if patients present within 3 days of onset. These findings need to be applied with caution, considering the limitations of our review.